Amorepacific Group
KRX:002790
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20 650
38 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Amorepacific Group
Amorepacific Group
Cash from Financing Activities
Amorepacific Group
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amorepacific Group
KRX:002790
|
Cash from Financing Activities
-₩85.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
-27%
|
|
|
AmorePacific Corp
KRX:090430
|
Cash from Financing Activities
-₩141.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Cosmax Inc
KRX:192820
|
Cash from Financing Activities
₩51.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cash from Financing Activities
-₩94B
|
CAGR 3-Years
34%
|
CAGR 5-Years
23%
|
CAGR 10-Years
-1%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cash from Financing Activities
-₩54.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
Cash from Financing Activities
₩19.3B
|
CAGR 3-Years
87%
|
CAGR 5-Years
19%
|
CAGR 10-Years
21%
|
|
Amorepacific Group
Glance View
Amorepacific Group, a titan in the global beauty and cosmetics industry, traces its roots back to South Korea in 1945, when its founder, Suh Sung-whan, began crafting and selling camellia nut oil. With a firm belief in harnessing the power of natural Asian ingredients, Suh established a brand that grew into a conglomerate revered for its commitment to innovation and high-quality products. Amorepacific's operation is a finely woven tapestry of comprehensive research and development, effective marketing strategies, and an expansive distribution network that spans Asia, Europe, and the Americas. The company's reputation for fusing ancient traditions with cutting-edge beauty technology underpins its diverse product range, from skincare and makeup to personal care and wellness products, all meticulously tailored to ever-evolving consumer preferences. The way Amorepacific Group makes money is as robust and diversified as its product portfolio. By adopting a multi-brand strategy, the company caters to different segments of the cosmetics market, with signature brands like Sulwhasoo, Laneige, Innisfree, and Etude House appealing to varied demographics and price points. Each brand harnesses the core values of innovation and quality, reinforcing Amorepacific's status as a leader in the beauty industry. Revenue streams are amplified by a combination of solid offline presence in department stores and continual adaptation to e-commerce trends, allowing access to a broader customer base. The group's commitment to sustainability and eco-friendly practices further enhances its brand image, attracting a socially-conscious clientele. Through strategic expansion and continuous adaptation, Amorepacific continues to forge a distinct identity in the ever-competitive cosmetic market landscape.
See Also
What is Amorepacific Group's Cash from Financing Activities?
Cash from Financing Activities
-85.7B
KRW
Based on the financial report for Sep 30, 2024, Amorepacific Group's Cash from Financing Activities amounts to -85.7B KRW.
What is Amorepacific Group's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-27%
Over the last year, the Cash from Financing Activities growth was 63%. The average annual Cash from Financing Activities growth rates for Amorepacific Group have been 21% over the past three years , 27% over the past five years , and -27% over the past ten years .
You don't have any saved screeners yet
